Cargando…
Targeting RET–interleukin-6 crosstalk to impair metastatic dissemination in breast cancer
RET (rearranged during transfection) is a receptor tyrosine kinase overexpressed in a subset of oestrogen receptor (ER)-positive breast cancers whose expression is regulated by ER signalling. The article from the Hynes group has reported for the first time that RET expression can also be regulated b...
Autores principales: | Morandi, Andrea, Isacke, Clare M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978856/ https://www.ncbi.nlm.nih.gov/pubmed/24467886 http://dx.doi.org/10.1186/bcr3608 |
Ejemplares similares
Cargando…
Are breast cancers driven by fusion genes?
por: Edwards, Paul AW, et al.
Publicado: (2012)
por: Edwards, Paul AW, et al.
Publicado: (2012)
Ejemplares similares
-
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts
por: Andreucci, Elena, et al.
Publicado: (2016) -
The 'alternative' EMT switch
por: Klingbeil, Pamela, et al.
Publicado: (2011) -
Crosstalk of parkin and Ret in dopaminergic neurons
por: Kramer, Edgar R.
Publicado: (2015) -
Sox4, EMT programs, and the metastatic progression of breast cancers: mastering the masters of EMT
por: Parvani, Jenny G, et al.
Publicado: (2013) -
A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer
por: Mulrane, Laoighse, et al.
Publicado: (2014)